CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.361
EU - Europa 7.936
AS - Asia 5.260
SA - Sud America 667
AF - Africa 234
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 10
Totale 22.502
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.207
RU - Federazione Russa 2.820
SG - Singapore 1.914
CN - Cina 1.724
IT - Italia 1.535
GB - Regno Unito 1.277
BR - Brasile 525
SE - Svezia 448
VN - Vietnam 436
FR - Francia 418
HK - Hong Kong 402
DE - Germania 349
IE - Irlanda 305
FI - Finlandia 296
KR - Corea 182
IN - India 134
NL - Olanda 92
CA - Canada 90
UA - Ucraina 74
EG - Egitto 73
TR - Turchia 71
JP - Giappone 58
ES - Italia 47
AR - Argentina 46
ID - Indonesia 46
BE - Belgio 44
PL - Polonia 44
PK - Pakistan 42
ZA - Sudafrica 40
BD - Bangladesh 39
AT - Austria 38
MX - Messico 34
CH - Svizzera 33
IR - Iran 32
AU - Australia 31
NG - Nigeria 31
IQ - Iraq 30
SA - Arabia Saudita 27
CL - Cile 23
EC - Ecuador 22
CZ - Repubblica Ceca 19
MA - Marocco 16
CO - Colombia 15
JO - Giordania 15
UZ - Uzbekistan 15
BJ - Benin 13
VE - Venezuela 13
GR - Grecia 12
TG - Togo 12
IL - Israele 11
MK - Macedonia 11
PY - Paraguay 11
NO - Norvegia 9
OM - Oman 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
LV - Lettonia 8
MY - Malesia 8
RO - Romania 8
TN - Tunisia 8
AZ - Azerbaigian 7
EU - Europa 7
HU - Ungheria 7
LT - Lituania 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
KE - Kenya 6
PT - Portogallo 6
DZ - Algeria 5
JM - Giamaica 5
NP - Nepal 5
PE - Perù 5
SD - Sudan 5
CI - Costa d'Avorio 4
PA - Panama 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
ML - Mali 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BY - Bielorussia 2
CG - Congo 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
Totale 22.465
Salva come PNG Salva come JPEG
Città #
Ashburn 1.126
Dallas 1.062
Moscow 994
Southend 987
Singapore 969
Chandler 786
San Jose 687
Hong Kong 389
Woodbridge 382
Ann Arbor 374
Verona 374
Jacksonville 331
Beijing 319
Dublin 306
The Dalles 234
New York 227
Houston 163
Los Angeles 149
Wilmington 126
Lawrence 122
Princeton 122
Ho Chi Minh City 120
Helsinki 114
Jinan 110
Nanjing 103
Milan 101
Hebei 88
Shenyang 88
Hanoi 84
Munich 77
Boardman 72
Buffalo 72
Council Bluffs 62
Redondo Beach 62
Santa Clara 62
Columbus 61
São Paulo 59
Washington 58
Orem 53
Tianjin 52
Rome 49
Zhengzhou 47
Tokyo 46
Changsha 44
Lancaster 44
Brussels 43
Dong Ket 43
London 42
Redwood City 42
Montreal 41
Ningbo 40
Turku 40
Cairo 38
Chennai 38
Hangzhou 38
Warsaw 38
Haikou 37
Nanchang 37
Amsterdam 35
Jakarta 35
Redmond 35
Guangzhou 33
Seattle 32
Johannesburg 31
Bologna 30
Taiyuan 30
Istanbul 28
Sindelfingen 28
Taizhou 28
Atlanta 27
Seoul 27
Abuja 24
Denver 23
Naples 23
Stockholm 23
Boston 22
Frankfurt am Main 22
Phoenix 22
Brooklyn 21
Chicago 21
Fuzhou 21
Da Nang 20
Dearborn 20
Falls Church 20
Paris 20
Tehran 20
Jiaxing 19
Shanghai 19
Norwalk 18
Nuremberg 18
Padova 18
Poplar 18
Vienna 18
Catania 17
Lappeenranta 17
Haiphong 16
Manchester 16
Toronto 16
Amman 15
Belo Horizonte 15
Totale 13.435
Salva come PNG Salva come JPEG
Nome #
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 624
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 444
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 332
The effectiveness of combining a home-based Digital motor Telerehabilitation program with conventional therapy in progressive multiple sclerosis: A study protocol for a multicenter, randomized controlled trial 303
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 300
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 276
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 261
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 252
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 251
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 232
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 231
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 225
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 224
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 218
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 217
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 217
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 216
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 216
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 214
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 214
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 214
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 213
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 209
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 208
A case of acute fulminant multiple sclerosis treated with alemtuzumab 208
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 207
Brentuximab vedotin: axonal microtubule's Apollyon 205
Cognitive onset in multiple sclerosis 204
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 204
“If You Can’t Control the Wind, Adjust Your Sail”: Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study 204
Risk factors for post-polio syndrome among an Italian population: a case-control study. 203
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 203
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 201
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 201
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 200
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 200
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 200
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 193
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 193
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 184
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 184
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 184
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 184
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 183
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 183
Amyloid myopathy: an intriguing diagnosis 183
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 182
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 178
Epilepsy in multiple sclerosis: The role of temporal lobe damage 177
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 176
Response to Nagai et al. 174
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 173
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 171
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 170
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 170
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 169
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 168
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 168
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 166
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 165
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 163
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 163
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 162
Evaluating upper upper limb dysfunctions in patients with multiple sclerosis: an electromyography cross sectional study 158
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 157
Promoting participatory research in chronicity: The ESPRIMO biopsychosocial intervention for young adults with multiple sclerosis 156
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 156
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 155
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 155
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 153
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 151
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 150
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 147
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 147
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 146
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 145
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 143
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 142
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 142
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 142
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 141
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 140
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 140
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 139
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 139
HCV-related nervous system disorders. 138
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 137
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 135
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 134
Long survival and clinical stability in Marburg's variant multiple sclerosis. 132
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 132
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 128
Prognostic factors of acute partial transverse myelitis. 127
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 125
Ofatumumab for relapsing forms of multiple sclerosis 125
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 124
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 124
Switching multiple sclerosis patients with breakthrough disease to second-line therapy. 122
Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial 121
A Panel of Exploratory CSF Biomarkers in Patients with an Initial Demyelinating Event of the CNS: Does It Add Relevant Information to Usual Work-Up? (P02.080) 120
Totale 18.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.918
article - articoli 65.731
book - libri 0
conference - conferenze 2.418
curatela - curatele 0
other - altro 491
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.278
Totale 139.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 35 104 96
2021/20221.177 98 418 31 123 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/20253.312 169 200 201 486 174 148 188 178 478 246 274 570
2025/20269.659 680 484 1.092 1.534 2.521 610 863 490 850 535 0 0
Totale 22.732